Style de citation APA (7e éd.)

Liu, Q., Tan, C., Yi, L., Wan, X., Peng, L., Li, J., . . . Zeng, X. (2021). Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer. Public Library of Science (PLoS).

Style de citation Chicago (17e éd.)

Liu, Qiao, Chongqing Tan, Lidan Yi, Xiaomin Wan, Liubao Peng, Jianhe Li, Xia Luo, et Xiaohui Zeng. Cost-effectiveness Analysis of Pembrolizumab Plus Chemotherapy as First-line Therapy for Extensive-stage Small-cell Lung Cancer. Public Library of Science (PLoS), 2021.

Style de citation MLA (8e éd.)

Liu, Qiao, et al. Cost-effectiveness Analysis of Pembrolizumab Plus Chemotherapy as First-line Therapy for Extensive-stage Small-cell Lung Cancer. Public Library of Science (PLoS), 2021.